Also trades as: RGT.L (LSE) · $vol 0M
RGT.AX ASX
Argent BioPharma Limited
1W: -6.2%
1M: +0.0%
3M: -58.3%
YTD: -46.4%
1Y: -78.6%
A$0.03 ($0.02)
-0.00 (-6.67%)
Weekly Expected Move ±8.3%
A$0
A$0
A$0
A$0
A$0
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Balance Sheet Trends
Total Assets
$2M
-77.1% ▼
Total Liabilities
$11M
-33.2% ▼
Shareholders Equity
-$9M
-67.5% ▼
Cash & Investments
$1M
+45.7% ▲
Total Debt
$8M
+693.2% ▲
Net Debt
$7M
+2024.5% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2024 |
|---|---|
| — Assets — | |
| Cash | $1M |
| Short-Term Investments | $0 |
| Cash & ST Investments | $1M |
| Net Receivables | $376K |
| Inventory | $133K |
| Other Current Assets | $0 |
| Total Current Assets | $2M |
| Property, Plant & Equip. | $438K |
| Goodwill & Intangibles | $0 |
| Long-Term Investments | $0 |
| Other Non-Current Assets | $0 |
| Total Non-Current Assets | $438K |
| Total Assets | $2M |
| — Liabilities — | |
| Accounts Payable | $2M |
| Short-Term Debt | $8M |
| Deferred Revenue | $0 |
| Other Current Liabilities | $0 |
| Total Current Liabilities | $11M |
| Long-Term Debt | $0 |
| Other Non-Current Liab. | $19K |
| Total Non-Current Liabilities | $267K |
| Total Liabilities | $11M |
| — Equity — | |
| Common Stock | $139M |
| Retained Earnings | -$148M |
| Accumulated OCI | $296K |
| Total Stockholders Equity | -$9M |
| Total Liabilities & Equity | $2M |
| — Key Metrics — | |
| Total Debt | $8M |
| Net Debt | $7M |
| Total Investments | $0 |